Clinical Trial of Vyoshadi Tablet in Hypothyroidism

An Open Labelled Randomized Controlled Trial to evaluate the Efficacy of Vyoshadi Guggul along with Thyroxine in Hypothyroidism - NIL

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080271

Enrollment

Registered

2025-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between the ages of 19 years to 50 years with irrespective sex, cast, religions. 2. Patient currently on Tab. Thyroxine 25 mcg to 100 mcg 3. Patient who has stopped treatment since 3 months or more and has any one of T3, T4 and TSH levels uncontrolled 4. Chronicity of hypothyroidism below 5 years.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
To Evaluate the efficacy of the Vyoshadi Guggul as an add-on effect in reduction of the symptoms of HypothyroidismTimepoint: 2 weeks 4 weeks 6 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Kunal Parashram Salunke

MAMs Sumatibhai Shah Ayurved College Hadapsar Pune

kunalsalunke209@gmail.com08788585617

Outcome results